Today's guest post comes from Geoffrey Chaiken and Matthew Chaiken, Co-founders of BlinkRx. Geoffrey and Matthew examine how efforts to improve patient access have contributed to an increasingly fragmented prescription journey. They suggest that a more integrated approach can reduce complexity, improve visibility and control for manufacturers, and create a simpler path to therapy for patients. To learn more about the BlinkRx Prescription Journey Management Platform, visit BlinkRx . Read on for Geoffrey and Matthew's insights. Read more » © 2006-2026 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved. This Feed is for…
Today's guest post comes from Geoffrey Chaiken and Matthew Chaiken, Co-founders of BlinkRx.
Geoffrey and Matthew examine how efforts to improve patient access have contributed to an increasingly fragmented prescription journey. They suggest that a more integrated approach can reduce complexity, improve visibility and control for manufacturers, and create a simpler path to therapy for patients.
To learn more about the BlinkRx Prescription Journey Management Platform, visit BlinkRx.
Read on for Geoffrey and Matthew's insights.
Read more »
US Pharma Marketing
